UAE Peripheral Vascular Devices Market Size and Forecast 2032

Market Overview

The UAE peripheral vascular devices market is projected to grow from USD 22.13 million in 2023 to USD 30.69 million by 2032, registering a CAGR of 4.17% during the forecast period.

The UAE peripheral vascular devices market is driven by the rising prevalence of vascular disorders, including peripheral artery disease (PAD), attributed to increasing rates of diabetes, obesity, and hypertension in the region. The growing geriatric population further fuels the demand for advanced medical technologies, enhancing the adoption of minimally invasive procedures. Government initiatives to strengthen healthcare infrastructure, coupled with increased healthcare expenditure, support market growth. Additionally, advancements in device technology, including drug-coated balloons and stents, contribute to improved patient outcomes, driving their adoption. The market also benefits from growing awareness and early diagnosis of vascular conditions through enhanced screening programs. Key trends shaping the market include a shift towards personalized treatment solutions and an increased focus on developing bioresorbable stents to minimize long-term complications. Furthermore, the rising preference for outpatient vascular surgeries and expanding partnerships between healthcare providers and device manufacturers are expected to create significant growth opportunities in the coming years.

The UAE peripheral vascular devices market is primarily driven by advanced healthcare infrastructure in major cities such as Abu Dhabi and Dubai, where a large concentration of healthcare facilities and specialized vascular centers are located. These cities serve as key hubs for medical tourism and the adoption of cutting-edge vascular technologies. Sharjah and Ras Al Khaimah are emerging markets with growing healthcare investments and awareness about vascular diseases. Key players in the market include global leaders such as Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, and Terumo Corporation, among others. These companies offer a range of innovative products, including drug-coated balloons, stents, and advanced catheters, contributing to the market’s growth. Through strategic partnerships, research and development, and a focus on minimally invasive treatments, these players are strengthening their presence in the UAE, enhancing market competition and patient access to advanced vascular solutions.

Market Insights

• The UAE peripheral vascular devices market is valued at USD 22.13 million in 2023 and is projected to reach USD 30.69 million by 2032, growing at a CAGR of 4.17%.
• Increasing prevalence of peripheral artery diseases and lifestyle-related risk factors such as diabetes and hypertension are driving market growth.
• Adoption of minimally invasive treatment methods, including drug-coated balloons and stents, is a key trend in the market.
• Technological advancements, such as bioresorbable stents and precision-guided devices, are enhancing treatment outcomes and fueling market expansion.
• Competitive landscape features major players like Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, and Terumo Corporation, contributing to innovation and market share.
• High cost of advanced devices and limited awareness about peripheral vascular diseases are major market restraints.
• Regional growth is driven by major cities like Abu Dhabi and Dubai, with emerging markets in Sharjah and Ras Al Khaimah gaining traction.

Market Drivers

Increasing Prevalence of Peripheral Artery Disease and Related Disorders

The rising prevalence of peripheral artery disease (PAD) and other vascular conditions in the UAE is a primary driver of the peripheral vascular devices market. A growing number of cases linked to risk factors such as diabetes, obesity, and hypertension has heightened the need for effective treatment solutions. For instance, a study by the Gulf Medical University found that the prevalence of PAD among adults aged 40 and above in the UAE is 22.7%, with the highest frequency among those aged 60 and above. With lifestyle changes and increasing adoption of sedentary habits, these health conditions are becoming more widespread, prompting healthcare providers to invest in advanced vascular treatment technologies. As a result, the demand for peripheral vascular devices, including stents, angioplasty balloons, and atherectomy systems, is steadily rising to address these complex conditions.

Advancements in Minimally Invasive Technologies

Technological advancements in minimally invasive vascular treatment methods are significantly driving market growth. Devices such as drug-coated balloons, bioresorbable stents, and specialized catheters offer improved patient outcomes by reducing recovery times and minimizing complications. For example, the German Medical Center in Dubai utilizes advanced techniques like Endovenous Laser Therapy (EVLT) and Radiofrequency Ablation (RFA) to treat varicose veins and other vascular conditions. Innovations in imaging technologies and device materials further enhance procedural precision and safety, making minimally invasive techniques preferable for both patients and healthcare providers. The continuous development of next-generation devices that integrate improved biocompatibility and durability contributes to the sustained adoption of peripheral vascular devices in clinical practice.

Government Support and Rising Healthcare Investments

Supportive government policies and increased investments in healthcare infrastructure are boosting the UAE peripheral vascular devices market. Initiatives aimed at enhancing the accessibility and quality of healthcare services align with the country’s broader goal of improving patient care standards. For instance, the UAE's new nationwide health insurance scheme, effective from January 1, 2025, mandates health insurance coverage for all private sector employees and domestic workers, ensuring broader access to healthcare. Public-private partnerships and the expansion of specialized healthcare facilities have created a conducive environment for the adoption of advanced medical technologies. Furthermore, growing medical tourism in the UAE increases demand for cutting-edge vascular treatment options, reinforcing market expansion.

Rising Awareness and Early Diagnosis Programs

Increasing awareness about vascular diseases and the benefits of early diagnosis is contributing to market growth. Public health campaigns and improved diagnostic capabilities have led to a higher rate of early detection and timely treatment. For example, the Ministry of Health and Prevention (MoHAP) in the UAE has launched the National Campaign for Early Detection of Hypertension, aiming to test 50,000 adults across the country. Screening initiatives focusing on high-risk populations further stimulate the adoption of peripheral vascular devices, as more patients seek minimally invasive therapeutic solutions. This proactive approach to managing vascular health strengthens the overall market outlook in the UAE.

Market Trends

Increased Collaborations and Strategic Partnerships

Collaborations between healthcare institutions, research organizations, and medical device manufacturers are rising in the UAE, fostering market innovation. Partnerships enable the development and adoption of cutting-edge technologies while enhancing market penetration. For example, the Ministry of Health and Prevention (MoHAP) has established strategic partnerships with several international medical device companies to enhance the quality of vascular treatments. Manufacturers are also working closely with healthcare providers to offer customized training programs, ensuring the optimal use of peripheral vascular devices. This trend of industry collaboration strengthens the market ecosystem, promoting the adoption of next-generation solutions to meet growing demand effectively.

Growing Adoption of Drug-Coated Balloons and Stents

The increasing preference for drug-coated balloons (DCBs) and drug-eluting stents (DES) is a significant trend shaping the UAE peripheral vascular devices market. These devices offer enhanced efficacy in preventing restenosis, a common complication in peripheral artery disease treatments. DCBs, in particular, have gained traction due to their ability to deliver localized drug therapy without leaving a permanent implant. The adoption of these advanced technologies reflects a broader shift towards solutions that improve long-term patient outcomes, reduce repeat interventions, and enhance procedural efficiency.

Emergence of Bioresorbable Stents for Long-Term Safety

A growing focus on developing bioresorbable stents marks another key trend in the UAE market. Unlike traditional metallic stents, bioresorbable stents are designed to dissolve after serving their therapeutic purpose, minimizing the risk of late-stage complications such as thrombosis. As healthcare providers increasingly prioritize patient safety and device biocompatibility, the demand for bioresorbable technology is expected to grow. Ongoing research and advancements in material science are further driving innovation in this segment, positioning it as a promising area for future growth.

Shift Towards Outpatient Peripheral Vascular Procedures

The healthcare sector’s emphasis on cost-effective and patient-centric care is driving a trend toward outpatient peripheral vascular procedures. Advances in minimally invasive devices and techniques have made same-day discharge increasingly feasible, reducing hospitalization costs and improving patient comfort. Specialized vascular centers and clinics focusing on outpatient treatments are gaining popularity in the UAE, contributing to the market’s evolution. This shift aligns with broader global trends favoring ambulatory surgical solutions, making high-quality care more accessible and efficient.

Market Challenges Analysis

High Cost of Advanced Devices and Procedures

The high cost associated with advanced peripheral vascular devices and minimally invasive procedures is a significant challenge in the UAE market. Innovative technologies such as drug-coated balloons, bioresorbable stents, and atherectomy systems often come with premium pricing, limiting their accessibility for certain patient groups. For instance, the average cost of a drug-coated balloon in the UAE can range from AED 10,000 to AED 15,000. Despite advancements in healthcare infrastructure and increased insurance coverage, affordability remains a barrier for many individuals, particularly for procedures not fully covered by health plans. Additionally, healthcare providers face cost pressures when investing in state-of-the-art equipment and training programs, which can hinder the widespread adoption of these technologies. Managing the cost-effectiveness of treatments while maintaining quality and innovation continues to be a pressing concern for market stakeholders.

Limited Awareness and Skilled Workforce Availability

Another critical challenge is the limited awareness of peripheral vascular diseases among the general population and the shortage of skilled healthcare professionals trained to perform advanced vascular procedures. Although public health initiatives have improved knowledge about cardiovascular diseases, awareness of peripheral artery disease (PAD) and related conditions remains relatively low. This gap often leads to delayed diagnosis and treatment, exacerbating patient outcomes. Furthermore, the growing demand for minimally invasive interventions requires specialized expertise, but the availability of trained vascular surgeons and interventional radiologists remains limited in certain regions. For instance, according to a report by the Dr. Sulaiman Al Habib Hospital, there is a shortage of skilled vascular surgeons in the UAE, which impacts the timely and effective treatment of vascular conditions. Addressing this challenge involves investing in comprehensive education programs, professional training, and public awareness campaigns to enhance early detection, treatment accessibility, and procedural success rates.

Market Opportunities

Rising Demand for Minimally Invasive Treatment Options

The growing preference for minimally invasive procedures presents significant opportunities for the UAE peripheral vascular devices market. Patients increasingly favor treatments that offer faster recovery times, reduced procedural risks, and shorter hospital stays. This trend is driving the demand for innovative devices such as drug-coated balloons, bioresorbable stents, and advanced atherectomy systems. Medical device manufacturers can capitalize on this shift by developing next-generation products that provide enhanced safety and efficacy. Additionally, the expansion of specialized vascular centers and ambulatory surgical clinics aligns with the rising adoption of minimally invasive techniques, creating avenues for increased market penetration. The government’s commitment to enhancing healthcare services and encouraging advanced medical technologies further strengthens this growth potential.

Technological Advancements and Personalized Medicine Solutions

Technological innovation and the growing emphasis on personalized treatment solutions present lucrative opportunities in the UAE market. Advancements in imaging technologies, precision-guided catheters, and bioengineered materials are improving the accuracy and outcomes of vascular interventions. Companies investing in research and development to create tailored solutions for individual patient needs can gain a competitive advantage. Furthermore, integrating artificial intelligence and machine learning into diagnostic and treatment processes enhances predictive accuracy and procedural efficiency, driving innovation-driven growth. Collaborations between healthcare providers, research institutions, and industry players to develop cutting-edge products and customized training programs will further stimulate market expansion and technological adoption.

Market Segmentation Analysis:

By Type:

The UAE peripheral vascular devices market is segmented by type into angioplasty balloons, angioplasty stents, catheters, guidewires, and others. Among these, angioplasty balloons and angioplasty stents hold the largest market share due to their widespread use in the treatment of peripheral artery disease (PAD). Angioplasty balloons, including drug-coated variants, are commonly employed to open blocked arteries, while angioplasty stents are used to maintain vessel patency after balloon angioplasty. Catheters and guidewires are integral components of these procedures, assisting in the precise delivery of balloons and stents. The "others" segment includes additional devices such as atherectomy systems and thrombectomy devices, which are increasingly adopted for specialized vascular interventions. The segment's growth is primarily driven by the increasing prevalence of vascular disorders, technological advancements, and the growing shift towards minimally invasive treatments that enhance patient outcomes and reduce recovery times.

By End-user:

The market is also segmented based on end-user, including hospitals, ambulatory surgical centers (ASCs), and specialty clinics. Hospitals currently dominate the end-user segment, driven by their comprehensive facilities and the ability to handle complex cases that require advanced peripheral vascular interventions. However, the ambulatory surgical center segment is witnessing significant growth due to the rising preference for outpatient procedures that reduce hospital stays and costs. ASCs are increasingly equipped with the necessary technologies to perform minimally invasive vascular surgeries, making them an attractive option for patients seeking faster recovery. Specialty clinics, focusing on cardiovascular and vascular health, are also expanding, driven by the increasing demand for personalized and specialized treatment options. The shift toward outpatient care and specialized centers is expected to drive further growth in the end-user segment.

Segments:

Based on Type:

• Angioplasty Balloons
• Angioplasty Stents
• Catheters
• Guidewires
• Others

Based on End-user:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Based on the Geography:

• Abu Dhabi
• Dubai
• Sharjah
• Ajman
• Fujairah
• Ras Al Khaimah
• Umm Al Quwain

Regional Analysis

Abu Dhabi and Dubai

Abu Dhabi and Dubai, which together account for over 60% of the market share. Abu Dhabi, as the capital and a major healthcare hub, holds a substantial portion of this market, driven by advanced healthcare infrastructure, high disposable income, and a growing elderly population that requires vascular treatments. The presence of leading medical facilities and specialized vascular centers further boosts the demand for peripheral vascular devices. Dubai, with its cosmopolitan appeal and thriving medical tourism industry, closely follows, representing a dynamic market for innovative medical technologies. Dubai’s position as a regional center for healthcare services, combined with a well-established network of private hospitals and clinics, increases the uptake of advanced vascular treatments, particularly in minimally invasive procedures. Both cities are poised to lead the market due to their continued investment in state-of-the-art medical equipment and expanding healthcare offerings.

Sharjah and Ajman Sharjah, holding approximately 12% of the UAE peripheral vascular devices market, presents a growing opportunity in the sector. As the third-largest emirate, Sharjah is witnessing an increased demand for advanced healthcare solutions driven by a rise in lifestyle-related diseases such as hypertension and diabetes, which contribute to peripheral vascular disorders. The emirate is also focusing on enhancing its healthcare infrastructure, which further facilitates market growth. Meanwhile, Ajman, with a smaller yet notable market share of around 7%, is gradually emerging as a key player in the peripheral vascular devices market. The rising healthcare awareness and governmental efforts to boost medical services and facilities in Ajman are fostering the adoption of modern medical technologies, including peripheral vascular devices, among the local population.

Fujairah and Ras Al Khaimah Fujairah and Ras Al Khaimah, while smaller markets compared to Abu Dhabi and Dubai, contribute approximately 5% and 8% of the UAE peripheral vascular devices market share, respectively. Fujairah, with its strategic location along the eastern coast of the UAE, is focusing on strengthening its healthcare services. Despite its smaller market, the emirate's proximity to regional markets enhances its appeal for specialized medical treatments. Similarly, Ras Al Khaimah’s increasing investment in healthcare infrastructure and rising awareness about peripheral vascular diseases are likely to further fuel growth in the peripheral vascular devices sector. Local government initiatives focused on expanding health facilities and promoting healthcare access contribute to a growing demand for innovative vascular treatment solutions in the region.

Umm Al Quwain

Umm Al Quwain, the smallest emirate in the UAE, holds around 3% of the market share in peripheral vascular devices. Despite its smaller market size, the emirate is witnessing gradual growth due to the broader healthcare initiatives undertaken by the government. Local healthcare facilities are evolving, and with a rising focus on medical advancements, Umm Al Quwain offers untapped potential for the adoption of advanced vascular treatment technologies. While still in the nascent stage of market development compared to other emirates, the growing recognition of vascular health issues is expected to drive future demand for peripheral vascular devices in the coming years.

Key Player Analysis

• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• Becton, Dickinson and Company
• Terumo Corporation
• Biotronik SE & Co. KG
• Cook Medical
• L. Gore & Associates, Inc.
• Cardinal Health
• AngioDynamics, Inc.

Competitive Analysis

The UAE peripheral vascular devices market is highly competitive, with several global leaders dominating the landscape. Key players include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Becton, Dickinson and Company, Terumo Corporation, Biotronik SE & Co. KG, Cook Medical, W. L. Gore & Associates, Inc., Cardinal Health, and AngioDynamics, Inc. Leading companies are focusing on product innovation, particularly in the development of minimally invasive solutions such as drug-coated balloons and bioresorbable stents, to meet the growing demand for safer, more effective treatments. These advancements are supported by significant investments in research and development, ensuring continuous improvements in device efficacy and patient outcomes. In addition to innovation, market players are expanding their regional presence through partnerships, collaborations, and the establishment of specialized vascular treatment centers. This helps improve accessibility to cutting-edge devices and enhances patient care. As healthcare providers focus on improving treatment efficiency, there is an increasing emphasis on integrated solutions that combine diagnostic and therapeutic capabilities.

The competitive environment is further shaped by pricing strategies and product differentiation. Companies are aiming to offer cost-effective yet high-quality products to cater to both public and private healthcare sectors. For instance, the UAE's healthcare sector is driven by digital innovation and technological advancements, with a federal budget of 5.2 billion AED dedicated to healthcare and community protection. The market's competitive nature, coupled with advancements in technology, is likely to drive further growth, with companies vying to capture a larger share of the expanding UAE vascular device market.

Recent Developments

• In December 2024, Terumo Interventional Systems launched the R2P™ NaviCross® peripheral support catheter in the U.S. This catheter is designed for enhanced performance in radial-to-peripheral procedures, addressing the need for advanced tools in treating PAD and critical limb ischemia.
• In October 2024, BD was highlighted as a key player in the peripheral vascular devices market forecast report. While specific recent product launches were not detailed, BD's ongoing commitment to R&D and innovation positions it strongly within this competitive landscape.
• In June 2023, Cook Medical announced new size options for its Advance Serenity PTA Balloon Catheter, used for treating peripheral artery disease (PAD).
• In June 2023, Biotronik launched the Oscar multifunctional peripheral catheter, designed for dilation of stenotic segments in peripheral vessels. The device features user-adjustable components and aims to improve procedural efficiency in treating peripheral arterial disease.

Market Concentration & Characteristics

The UAE peripheral vascular devices market exhibits moderate concentration, with a few leading global companies holding a substantial share, while several regional players contribute to the competitive landscape. The market is characterized by the presence of established multinational firms that offer a wide range of advanced vascular treatment solutions, including drug-coated balloons, stents, and catheters. These companies benefit from extensive R&D capabilities, enabling them to drive innovation and improve patient outcomes. The presence of strong healthcare infrastructure in key regions like Abu Dhabi and Dubai further enhances the market dynamics, facilitating the widespread adoption of advanced vascular devices. Additionally, the market is marked by the growing preference for minimally invasive procedures, which has resulted in increased demand for cutting-edge technologies such as bioresorbable stents and precision-guided catheters. This shift towards less invasive, more effective treatments is shaping the characteristics of the market, encouraging companies to develop devices that offer shorter recovery times, reduced complications, and enhanced long-term results. Moreover, the UAE’s healthcare sector is continuously expanding, with both public and private institutions investing in state-of-the-art medical equipment, making it an attractive market for vascular device manufacturers. This favorable environment drives growth and fosters a competitive yet collaborative market atmosphere.

Report Coverage

The research report offers an in-depth analysis based on Type, End-user and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

1. The UAE peripheral vascular devices market is expected to grow significantly, driven by an aging population and an increase in lifestyle-related diseases.
2. Demand for minimally invasive vascular treatments will continue to rise as patients seek quicker recovery and less risk.
3. Technological advancements, such as bioresorbable stents and drug-coated balloons, will play a critical role in enhancing treatment outcomes.
4. The government’s investment in healthcare infrastructure will facilitate increased adoption of advanced peripheral vascular devices.
5. Key cities like Abu Dhabi and Dubai will remain major hubs for the latest vascular treatment technologies.
6. The market will witness the emergence of newer device categories designed to improve procedural precision and minimize complications.
7. The healthcare tourism sector will fuel demand for high-quality peripheral vascular treatments, attracting international patients.
8. Partnerships and collaborations between device manufacturers and healthcare providers will foster innovation and expand market access.
9. Regional expansion by key players into underserved markets such as Sharjah and Ras Al Khaimah will drive further growth.
10. Rising healthcare awareness and education on vascular diseases will contribute to an increase in demand for peripheral vascular interventions.

Rising Prevalence of Peripheral Artery Disease and Related Disorders

The increasing rates of diabetes, obesity, and hypertension in the UAE are leading to a higher incidence of peripheral artery disease (PAD) and other vascular conditions, driving demand for effective peripheral vascular devices and advanced treatment solutions.

Advancements in Minimally Invasive Technologies

Technological innovations such as drug-coated balloons, bioresorbable stents, and precision-guided catheters are improving patient outcomes and reducing recovery times, making minimally invasive procedures more attractive to both patients and healthcare providers.

Government Support and Healthcare Investments

The UAE government’s initiatives to strengthen healthcare infrastructure, expand insurance coverage, and promote public-private partnerships are facilitating broader access to advanced vascular treatments and supporting market growth.

Growing Awareness and Early Diagnosis Programs

Public health campaigns and enhanced screening initiatives are increasing early detection of vascular diseases, leading to timely interventions and greater adoption of peripheral vascular devices.

Expansion of Outpatient and Specialized Vascular Centers

The shift toward outpatient procedures and the growth of specialized vascular clinics are making advanced treatments more accessible, reducing hospital stays, and supporting the adoption of innovative vascular devices.

Note: The depth of individual sections depends on data availability for this market. Volume, capacity, trade and other unit-based metrics are included where applicable.